Oxybutynin 70771-1086-05
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 10, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA202332
Need to source Oxybutynin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Oxybutynin Chloride | 5 mg/1 |
Drug Class
Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]
Selected Package
70771-1086-05Selected500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-5)
Other packages for this product(5)
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-1)
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-3)
10 BLISTER PACK in 1 CARTON (70771-1086-4) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (70771-1086-2)
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-6)
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-9)